I wonder if any gamblers noticed my post 334 on the GMC thread yesterday.
It looks as though bottom fishing can sometimes pay off.

Great news 'Squidd' sp will lift-off when the America wakes up around 2.00pm

We will show them!

I continued to buy this share after the second crash and now, following an upbeat statement from the ceo, it seems to be crawling out of the pit at last.
Any further thoughts out there.
sd.

ELA certainly seems to on the road to recovery as the new chairman makes a huge stock purchase and many medics are saying that with all its faults, their flagship drug Tysabti can't be worse than the disease.
sd.

looks like confidence is returning.

Maybe was that confidence short lived?? The market has not taken the same view as the chairman. Any thoughts?

Have just added in my ISA. Mine was the 3503 buy via comdirect after baling out of ARK. Hope I got it right, but it seems to me that with all the gloom in the AIM market it's safer either to be in cash or in shares that have already plunged.
sd.

according to another site.......Rumour......Elan Corporation (ELN) $5.87 to be bought by WYETH (WYE) for $14 per share.....dyor

Wisemove: Thanks for that titbit; something certainly moved the price today, a bit marred by a hefty sell at the closing bell over here and little movement on the NASDAQ for either ELA or Wyeth. But looking forward to tomorrow.
sd.

squidd....at close US..$6.97/+9.5%

Vivid blue again! And some heavy selling; maybe someone wants these shares.
sQd.

Another day of heavy selling and hefty price rise. Everyone on this BB should now be showing a healthy profit, especially those who bought into the second crash - it certainly brightened up my ISA. Interesting to see what Fri 13th brings - maybe a revelation.
sd.

squidd ELA still looking good on the recovery play front I see I have added KUJ to the recovery list of OSH APH ELA and others we have and along with that UNG is worth a serious look now with bottomed price at below price to book of 1.

The wife is watching casualty and I'm scouring the internet and I'm baffled. According to PUBMED the US National Library of Medicine, the disease for which ELA is taking all the flak - PMLE - was first disclosed in 1958, about 40 years before ELA came on the scene with their new drugs, so how can they be blamed. Are there any medics who can explain.
sd.

Live webcast of today's ELA A.G.M. now playing. Access via elan.com.

Much of the discussion focussed on the latest drugs and directors expressed cautious optimism about the future in this morning's question time at the AGM. They revealed that there are around 100,000 MS sufferers in the US who are currently recieving no medication, and the talk was not of whether, but when their flagship drug Tysabri would return to the market.

agm this morning....excellent news....this is going to go balistic.......sorry....has gone ballistic and the US has even opened yet (pre market +11% and rising!!!!)

I had e-mailed Elan with my query about PMLE [post 31} and had no direct reply, but this was aired in the AGM and the medics put it into perspective - too complex for laymen like me to report here.
Meanwhile they are looking optimistic so far, over on NASDAQ.
sd.

Some new heavyweight board appointments announced today, seem to have brought ELA firmy back onto its recovery course.
sd.

squidd ELA still rising and OSH too so good news all round.